Jacqueline Studer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jacqueline Studer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jacqueline Studer. Jacqueline Studer is CVP, Gen. Counsel & Secretary in IDEXX LABORATORIES INC /DE ($IDXX) and See Remarks in IDEXX LABORATORIES INC /DE ($IDXX) and EVP and General Counsel in ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. ($MDRX) and Sr. VP and General Counsel in ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. ($MDRX).
Latest Insider Trading Transactions of Jacqueline Studer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,156 | 91,948 | 708 | |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.06 | 834 | 173,523 | 4,389 | 5.2 K to 4.4 K (-15.97 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 212.05 | 472 | 100,089 | 5,223 | 5.7 K to 5.2 K (-8.29 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 211.70 | 1,223 | 258,907 | 5,695 | 6.9 K to 5.7 K (-17.68 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,156 | 91,948 | 6,918 | 5.8 K to 6.9 K (+20.06 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 178.26 | 1,714 | 305,538 | 6,293 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 141.60 | 2,219 | 314,210 | 5,948 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 1 | 68 | 1,474 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 4,700 | 318,895 | 7,927 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 100 | 7,954 | 1,864 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 2,866 | 227,962 | 2,866 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 209.18 | 1,714 | 358,533 | 5,762 | 7.5 K to 5.8 K (-22.93 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 178.26 | 1,714 | 305,538 | 7,476 | 5.8 K to 7.5 K (+29.75 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.95 | 2,219 | 463,665 | 5,762 | 8 K to 5.8 K (-27.80 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 7,981 | 5.8 K to 8 K (+38.51 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.90 | 1 | 209 | 5,762 | 5.8 K to 5.8 K (-0.02 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 1 | 68 | 5,763 | 5.8 K to 5.8 K (+0.02 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.54 | 4,700 | 980,133 | 5,762 | 10.5 K to 5.8 K (-44.92 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 4,700 | 318,895 | 10,462 | 5.8 K to 10.5 K (+81.57 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.80 | 100 | 20,780 | 5,762 | 5.9 K to 5.8 K (-1.71 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 100 | 7,954 | 5,862 | 5.8 K to 5.9 K (+1.74 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.54 | 2,866 | 594,796 | 5,762 | 8.6 K to 5.8 K (-33.22 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 2,866 | 227,962 | 8,648 | 5.8 K to 8.6 K (+49.57 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 169 | 0 | 3,591 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 212 | 0 | 3,760 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 405 | 0 | 3,972 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 345 | 0 | 4,377 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 206.94 | 345 | 71,394 | 5,762 | 6.1 K to 5.8 K (-5.65 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 169 | 0 | 6,107 | 5.9 K to 6.1 K (+2.85 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 212 | 0 | 5,938 | 5.7 K to 5.9 K (+3.70 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 405 | 0 | 5,726 | 5.3 K to 5.7 K (+7.61 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 345 | 0 | 5,321 | 5 K to 5.3 K (+6.93 %) |
| Nov 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 201.28 | 3,313 | 666,823 | 4,951 | 8.3 K to 5 K (-40.09 %) |
| Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 1,129 | 0 | 4,722 | |
| Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 254.04 | 524 | 133,117 | 8,239 | 8.8 K to 8.2 K (-5.98 %) |
| Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 1,129 | 0 | 8,763 | 7.6 K to 8.8 K (+14.79 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | S | 141.60 | 2,219 | 314,210 | 8,167 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 9,400 | 637,790 | 12,627 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 245.06 | 3,264 | 799,887 | 7,634 | 10.9 K to 7.6 K (-29.95 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 244.15 | 2,806 | 685,089 | 10,898 | 13.7 K to 10.9 K (-20.48 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 243.36 | 5,549 | 1,350,399 | 13,704 | 19.3 K to 13.7 K (-28.82 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 19,253 | 17 K to 19.3 K (+13.03 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 9,400 | 637,790 | 17,034 | 7.6 K to 17 K (+123.13 %) |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 2 | 136 | 1,475 | |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,783 | 141,820 | 2,512 | |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 2 | 136 | 7,634 | 7.6 K to 7.6 K (+0.03 %) |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,783 | 141,820 | 7,632 | 5.8 K to 7.6 K (+30.48 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 8,598 | 683,885 | 5,732 | |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 242.87 | 3,010 | 731,037 | 5,849 | 8.9 K to 5.8 K (-33.98 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 242.10 | 5,588 | 1,352,834 | 8,859 | 14.4 K to 8.9 K (-38.68 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 8,598 | 683,885 | 14,447 | 5.8 K to 14.4 K (+147.00 %) |
| May 31 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,185 | 94,255 | 4,295 | |
| May 31 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 209.98 | 475 | 99,741 | 5,825 | 6.3 K to 5.8 K (-7.54 %) |
| May 31 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,185 | 94,255 | 6,300 | 5.1 K to 6.3 K (+23.17 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 212 | 0 | 5,851 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 406 | 0 | 6,063 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 346 | 0 | 6,469 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 841 | 0 | 6,815 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 178.26 | 560 | 99,826 | 560 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 178.26 | 8,007 | 1,427,328 | 8,007 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 178.26 | 298 | 53,121 | 5,077 | 5.4 K to 5.1 K (-5.54 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 212 | 0 | 5,375 | 5.2 K to 5.4 K (+4.11 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 406 | 0 | 5,163 | 4.8 K to 5.2 K (+8.53 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 346 | 0 | 4,757 | 4.4 K to 4.8 K (+7.84 %) |
| Sep 06 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 1,129 | 0 | 5,974 | |
| Sep 06 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 154.98 | 365 | 56,568 | 4,339 | 4.7 K to 4.3 K (-7.76 %) |
| Sep 06 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 1,129 | 0 | 4,704 | 3.6 K to 4.7 K (+31.58 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 406 | 0 | 7,103 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 346 | 0 | 7,509 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 1,059 | 0 | 7,855 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 141.60 | 10,386 | 1,470,658 | 10,386 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 141.60 | 273 | 38,657 | 3,496 | 3.8 K to 3.5 K (-7.24 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 406 | 0 | 3,769 | 3.4 K to 3.8 K (+12.07 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 346 | 0 | 3,363 | 3 K to 3.4 K (+11.47 %) |
| Dec 02 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 800 | 63,632 | 5,480 | |
| Dec 02 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 800 | 63,632 | 2,974 | 2.2 K to 3 K (+36.80 %) |
| Sep 02 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 1,129 | 0 | 6,796 | |
| Sep 02 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 113.16 | 365 | 41,303 | 2,122 | 2.5 K to 2.1 K (-14.68 %) |
| Sep 02 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 1,129 | 0 | 2,487 | 1.4 K to 2.5 K (+83.14 %) |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Option Exercise | M | 0.00 | 346 | 0 | 7,925 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Option Exercise | A | 0.00 | 2,027 | 0 | 8,271 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Option Exercise | A | 67.85 | 1,477 | 100,214 | 1,477 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Option Exercise | A | 67.85 | 22,027 | 1,494,532 | 22,027 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Payment of Exercise | F | 67.85 | 130 | 8,821 | 1,208 | 1.3 K to 1.2 K (-9.72 %) |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | See Remarks | Buy | M | 0.00 | 346 | 0 | 1,338 | 992 to 1.3 K (+34.88 %) |
| Sep 03 2015 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 1,130 | 0 | 6,244 | |
| Sep 03 2015 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 70.54 | 365 | 25,747 | 847 | 1.2 K to 847 (-30.12 %) |
| Sep 03 2015 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 1,130 | 0 | 1,212 | 82 to 1.2 K (+1,378.05 %) |
| Sep 05 2012 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | Sr. VP and General ... | Payment of Exercise | F | 10.50 | 218 | 2,289 | 101,102 | 101.3 K to 101.1 K (-0.22 %) |
| Sep 05 2012 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | Sr. VP and General ... | Payment of Exercise | F | 10.50 | 2,188 | 22,974 | 101,320 | 103.5 K to 101.3 K (-2.11 %) |
| Jun 01 2012 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | Sr. VP and General ... | Grant | A | 0.00 | 22,790 | 0 | 103,508 | 80.7 K to 103.5 K (+28.23 %) |
| May 03 2012 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | Sr. VP and General ... | Grant | A | 0.00 | 25,047 | 0 | 80,718 | 55.7 K to 80.7 K (+44.99 %) |
| May 03 2012 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | Sr. VP and General ... | Grant | A | 0.00 | 25,047 | 0 | 55,671 | 30.6 K to 55.7 K (+81.79 %) |
| Sep 02 2011 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | EVP and General Cou ... | Grant | A | 0.00 | 2,784 | 0 | 30,624 | 27.8 K to 30.6 K (+10.00 %) |
| Sep 02 2011 | MDRX | ALLSCRIPTS HEALTHC ... | Studer Jacqueline | EVP and General Cou ... | Grant | A | 0.00 | 27,840 | 0 | 27,840 | 0 to 27.8 K |
Page: 1